- Home
- MBOT vs IOBT Comparison
MBOT vs IOBT Comparison
Compare MBOT & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBOT
- IOBT
- Stock Information
- Founded
- MBOT 2010
- IOBT 2014
- Country
- MBOT United States
- IOBT Denmark
- Employees
- MBOT N/A
- IOBT N/A
- Industry
- MBOT Medical/Dental Instruments
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- MBOT Health Care
- IOBT Health Care
- Exchange
- MBOT Nasdaq
- IOBT Nasdaq
- Market Cap
- MBOT 50.4M
- IOBT 57.9M
- IPO Year
- MBOT N/A
- IOBT 2021
- Fundamental
- Price
- MBOT $1.46
- IOBT $1.16
- Analyst Decision
- MBOT Strong Buy
- IOBT Strong Buy
- Analyst Count
- MBOT 1
- IOBT 3
- Target Price
- MBOT $9.00
- IOBT $9.33
- AVG Volume (30 Days)
- MBOT 896.8K
- IOBT 217.8K
- Earning Date
- MBOT 03-25-2025
- IOBT 05-13-2025
- Dividend Yield
- MBOT N/A
- IOBT N/A
- EPS Growth
- MBOT N/A
- IOBT N/A
- EPS
- MBOT N/A
- IOBT N/A
- Revenue
- MBOT N/A
- IOBT N/A
- Revenue This Year
- MBOT N/A
- IOBT $59.29
- Revenue Next Year
- MBOT N/A
- IOBT N/A
- P/E Ratio
- MBOT N/A
- IOBT N/A
- Revenue Growth
- MBOT N/A
- IOBT N/A
- 52 Week Low
- MBOT $0.82
- IOBT $0.66
- 52 Week High
- MBOT $3.38
- IOBT $1.79
- Technical
- Relative Strength Index (RSI)
- MBOT 42.47
- IOBT 67.95
- Support Level
- MBOT $1.60
- IOBT $0.90
- Resistance Level
- MBOT $1.81
- IOBT $1.37
- Average True Range (ATR)
- MBOT 0.12
- IOBT 0.10
- MACD
- MBOT 0.00
- IOBT 0.03
- Stochastic Oscillator
- MBOT 22.22
- IOBT 60.97
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.